The trial’s outcomes will inform future moves that the sport will take in advancing the welfare of players. In the lead-up to Super Rugby Trans-Tasman, teams have been embracing the study with all participating players undertaking baseline testing under controlled conditions to provide an accurate comparison for use when a player comes off the field for an HIA.ĭata collected from the NeuroFlex VR testing will be used to compare the accuracy of concussion identification based on the eye and head movements versus the current HIA process. Numerous scientific studies have demonstrated that oculomotor functions are altered at the time of, or shortly after a concussion and the ground-breaking trial aims to verify the test’s diagnostic accuracy. The NeuroFlex eye-tracking technology is an objective test that could further improve rugby’s approach to brain health, supporting doctors to make the right decision. This innovative way to identify altered oculomotor function and head movement will also be used within the six-stage graduated return-to-play process to monitor players returning from injury and protect their health. The aim is to objectively determine whether the eye-tracking system could further enhance the HIA process, which currently operates at 90 percent accuracy in elite competitions. The technology is being used alongside the current Head Injury Assessment (HIA) protocols when players are removed from the field of play.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |